Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Association of tumor-informed circulating tumor DNA dynamics with radiologic disease assessment in a single-center real-world sarcoma cohort

At a single sarcoma center, 20 patients were screened for tumor-informed ctDNA targets and 14 (70%) had a trackable target. Across 67 paired ctDNA and imaging assessments, agreement was 88.1% (Cohen's kappa=0.755). Using imaging as the reference, ctDNA had a descriptive sensitivity of 80.0% and specificity of 94.6% for progressive disease. These estimates did not account for repeated measures within patients.

BMC CancerPubMed 42947038DOI 10.1186/s12885-026-17180-y